Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.


Severe hepatitis outbreak in children linked to AAV2 virus

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout

Nature 617, 471-472 (2023)



  1. Alexander, E. C. & Deep, A. JAMA Netw. Open 5, e2237091 (2022).

    Article  PubMed  Google Scholar 

  2. Ho, A. et al. Nature 617, 555–563 (2023).

    Article  Google Scholar 

  3. Morfopoulou, S. et al. Nature 617, 564–573 (2023).

    Article  Google Scholar 

  4. Servellita, V. et al. Nature 617, 574–580 (2023).

    Article  Google Scholar 

  5. Gutierrez Sanchez, L. H. et al. N. Engl. J. Med. 387, 620–630 (2022).

    Article  PubMed  Google Scholar 

  6. Kelgeri, C. et al. N. Engl. J. Med. 387, 611–619 (2022).

    Article  PubMed  Google Scholar 

  7. Karpen, S. J. N. Engl. J. Med. 387, 656–657 (2022).

    Article  PubMed  Google Scholar 

  8. Sant’Anna, T. B. & Araujo, N. M. Virol. J. 19, 173 (2022).

    Article  PubMed  Google Scholar 

  9. Shen, W., Liu, S. & Ou, L. Front. Immunol. 13, 1001263 (2022).

    Article  PubMed  Google Scholar 

  10. Brevini, T. et al. Nature 615, 134–142 (2022).

    Article  PubMed  Google Scholar 

Download references

Competing Interests

F.T.’s laboratory has received research funding at Charité – Universitätsmedizin Berlin from Allergan, Bristol Myers Squibb, Gilead and Inventiva. F.T. has acted as a consultant for AstraZeneca, Allergan, Bayer, Boehringer Ingelheim, Galapagos, Gilead, Intercept, Inventiva, Madrigal, Novartis, Novo Nordisk and Pfizer.


Latest on:

Nature Careers


Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing


Quick links